Successful End-of-Phase 2 Meeting with FDA Results in Alignment on Phase 3 Plans for CLS-AX in Wet AMD -- Asia-Pacific Partner’s New Drug ...
For women with early-stage breast cancer, breast-conserving therapy (BCT)—including radiation therapy (RT)—leads to ...
16 小时
Zacks Investment Research on MSNIONS Out-Licenses ex-U.S. Rights for Rare Disease Drug Tryngolza to SobiIonis Pharmaceuticals IONS signed a license agreement with Sweden-based Sobi. Per the terms, Sobi will acquire exclusive ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果